RecruitingNCT06746766
Registry Study on Rare Cancers in Korea
Sponsor
Yonsei University
Enrollment
500 participants
Start Date
Nov 18, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to determine the participation rate of patients with registered rare cancers in clinical research.
Eligibility
Min Age: 19 Years
Plain Language Summary
Simplified for easier understanding
This is a registry study in Korea that collects data on patients with rare cancers — unusual cancer types that are not commonly encountered — to better understand how these cancers behave and how they are treated in real-world clinical settings.
**You may be eligible if...**
- You are 19 years or older
- You have been diagnosed with a rare cancer (as defined by Korean clinical guidelines)
- Your life expectancy is at least 3 months
**You may NOT be eligible if...**
- You have serious, unstable medical or psychiatric conditions that prevent safe participation
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06746766
Related Trials
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
NCT075241141 location
Genomic Investigation of Unusual Responders
NCT037405031 location
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
NCT029069437 locations
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
NCT041660061 location